Cancer Biology (MS)

专业详情

The Cancer Biology PhD program was established in 1978 at Stanford University. During the past four decades, the understanding of cancer has increased dramatically with the discovery of oncogenes and tumor suppressor genes, DNA damage and repair pathways, cell cycle regulation, angiogenesis and responses to hypoxia, and the molecular basis of metastasis, among others. In addition, parallel analysis methods, including genomic and proteomic approaches, have begun to refine and redefine the taxonomy of cancer diagnosis. This explosion of basic and clinical science has, in turn, resulted in the first successful cancer chemotherapies and immunotherapies based on knowledge of specific molecular targets. Stanford presents a unique environment to pursue interdisciplinary cancer research because the School of Medicine, the School of Humanities and Sciences, and the School of Engineering are located on a single campus, all within walking distance of one another.

Students are not limited to a single department in choosing their research advisors. The Cancer Biology PhD program currently has approximately 65 graduate students in various basic science and clinical departments throughout the School of Medicine and School of Humanities and Sciences. A training grant from the National Cancer Institute supports many students.

The Cancer Biology PhD program is committed to fostering a diverse community of students. The program welcomes all individuals and strives to support them so they achieve their full potential. It values the diversity of its students because culture, socioeconomic and educational background, race, ethnicity, gender, sexual orientation, physical ability, life experiences, hobbies, and interests allow the program as a group to reach a greater level of innovation in cancer research.